Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers
- PMID: 38821641
- DOI: 10.1016/j.cll.2023.08.004
Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers
Abstract
This review focuses on the diagnostic, prognostic, and predictive molecular biomarkers in ovarian epithelial neoplasms in the context of their morphologic classifications. Currently, most clinically actionable molecular findings are reported in high-grade serous carcinomas; however, the data on less common tumor types are rapidly accelerating. Overall, the advances in genomic knowledge over the last decade highlight the significance of integrating molecular findings with morphology in ovarian epithelial tumors for a wide-range of clinical applications, from assistance in diagnosis to predicting response to therapy.
Keywords: BRCA; Endometrioid; Epithelial; High-grade serous; Homologous recombination; Low-grade serous; Molecular; Mucinous; Ovarian carcinoma.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure L.L. Ritterhouse has received honoraria/consulting fees from Abbvie, Personal Genome Diagnostics, Bristol Myers Squibb, Loxo Oncology, Amgen, and Merck.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
